BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Alferon N interferon alfa-n3 regulatory update

Hemispherx Biopharma said GP Pharm submitted a regulatory application in Argentina for Hemispherx's Alferon N interferon alfa-n3 to treat genital warts. Late last year,...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >